The CoSyne team had a fantastic time at the JP Morgan Healthcare conference in San Francisco last week!
#JPM2026 #CoSyneTherapeutics #BioTech #RareDisease #GBM
Great to have everyone together for our company offsite yesterday! It’s always great to connect as a full team, celebrate our wins, and align on the next phase of our journey 🙌🧠🚀
#CoSyneTherapeutics #Glioblastoma #Bioinformatics #DrugDiscovery #BrainCancerResearch
A huge congratulations to our bioinformatician Grant who conquered the great Steall Marathon in the Scottish Highlands on the weekend! He finished with an impressive time of 7:03 and placed 85 of 231 finishers. 🏃 🏔️ 🎖️
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #Fundraising
We’re standing with Brain Cancer Justice, a new group founded by patients and advocates fighting for change. [1/3]
petition.parliament.uk/petitions/73...
#CoSyneTherapeutics #BrainCancerJustice #BrainCancer #Petition
Behind the scenes: our team of bioinformaticians is diving deep into biological data, using cutting-edge analysis to uncover potential new drugs for GBM. Data-driven discovery at its finest! 🔬
#CoSyneTherapeutics #GBM #Bioinformatics #DrugDiscovery #BrainCancerResearch
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma (GBM) patients.
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.
Read more about our work on our website: www.cosyne.com
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.
Read more about our work on our website: www.cosyne.com
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.
Read more about our work on our website: www.cosyne.com
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
GBM patients have faced decades without a new approved therapy.
At CoSyne, we’re working on something that could change that. Stay tuned.
www.gliosyne.com
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
The last FDA-approved therapy for glioblastoma (GBM) was in 2009.
15 years with no new treatments — patients deserve better.
Follow us for updates on what we're doing to bring new treatments to patients.
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
Only 1% of the UK’s yearly cancer research budget goes to brain cancer. In just 3 years, CoSyne Therapeutics has directed £6M into brain cancer research - driving novel insights and pushing the field forward.
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery
Cells aren’t the only thing we grow at CoSyne Therapeutics – this year we are taking part in a chilli growing contest! We have lots of plants to brighten our office space in Cambridge.
#CosyneTherapeutics #BrainCancerResearch #DrugDiscovery #Biotech
CoSyne Therapeutics is committed to advancing new treatment options for patients.
Read more about our work on our website: www.cosyne.com
#CosyneTherapeutics #BrainCancerResearch #Neuroscience #DrugDiscovery #Glioblastoma #GBM #BrainCancer #BrainTumor